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Background: Loss of function in genes required for telomere maintenance result in disorders known as
telomeropathies, which are characterized by a pattern of symptoms including generalized and specific
lymphocytopenias as well as very short telomere length and disease anticipation.
Methods: Because human LARP7 is the most likely ortholog of the Tetrahymena p65 protein, which is required for
telomerase activity in that organism, we investigated the effects of LARP7 silencing in human cells as well as in two
distinct families with Alazami syndrome (loss of function of LARP7).
Results: Depletion of LARP7 caused a reduction in telomerase enzymatic activity and progressively shorter
telomeres in human cancer cell lines. Alazami syndrome patients from two separate cohorts exhibited very short
lymphocyte telomeres. Further, wild-type offspring of LARP7 mutant individuals also had very short telomeres,
comparable to what is observed in telomerase (hTERT) mutant cohorts.
Conclusions: Together, these experiments demonstrate that in addition to the readily apparent developmental
disorder associated with LARP7 deficiency, an underlying telomeropathy exists even in unaffected siblings of these
individuals.Background
Telomeropathies are disorders of impaired telomere main-
tenance, which are characterized by symptoms which can
include short telomeres, anemia, idiopathic pulmonary fi-
brosis, intrauterine growth retardation and the “classic
triad” of keratosis, nail dystrophy and leukoplakia [1]. Mu-
tations in genes required for telomere maintenance, such as
the telomerase catalytic and RNA components, TERC and
TERT have been found to cause telomeropathies in an
autosomal dominant pattern of inheritance; loss-of-
function in a number of other genes such as DKC1, NHP2,
TCAB1, TIN2/TINF2, RTEL1, PARN, and CTC1 [1, 2]
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maintenance. Importantly, a number of the telomeropathies
demonstrate a developmental phenotype in a recessive
manner characterized by the overt symptoms of telomero-
pathy, while individuals who are carriers for the mutation
are phenotypically normal but still perpetuate the inter-
generational decrease in telomere length [3]. In later
generations of a family with such a mutation, diseases such
as idiopathic pulmonary fibrosis and cirrhotic liver disease
can manifest in individuals who carry a mutant allele but
display no other symptoms of a telomeropathy [1]. Because
of the increasing number of genes that when mutated can
induce telomeropathies as well as the very large number of
genes known to modulate telomere length in model
organisms such as Saccharomyces cerevisiae [4–7], it is
likely that many telomere maintenance disorders remain
undiscovered in humans, and that further exploration of
premature telomere length shortening in humans will
reveal novel telomeropathies.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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family of proteins that includes LARP3 (previously
known as the La antigen). LARP3 has been shown to act
as a negative regulator of telomerase activity via binding
to TERC, the RNA component of telomerase [8]. Fur-
ther, LARP7 is the human ortholog of the p65 protein in
Tetrahymena thermophila that is required for telomer-
ase assembly in that organism [9]. LARP7 knockout
mice display a defect in primordial germ cell develop-
ment driven by an increase in expression of p15INK4b
[10]. In addition, embryonic stem cells deficient for
LARP7 exhibit decreased levels of Lin28 mRNA, com-
promising their self-renewal [11]. In Tetrahymena, de-
pletion of the LARP7 ortholog, p65, leads to lower levels
of TERT protein as well as telomerase RNA (TERC)
component abundance, in addition to its role in telomer-
ase holoenzyme assembly [9, 12, 13]. Because of the
many associations between the probably ortholog of
LARP7 in Tetrahymena and telomerase, as well as theFig. 1 In vitro behavior of LARP7 knockdown cells. Extent of LARP7 knockdow
~90 % loss of LARP7 protein in all three shRNAs examined (b) (n = 1 for each
enzymatic activity (c) (n = 3) and progressive time-dependent telomere shorteknown telomerase-relevant function of the La-family
protein LARP3, we decided to investigate how LARP7
impacts telomere maintenance in humans, both in tissue
culture as well as in two independent cohorts of human
LARP7 loss-of-function mutants.
Methods
A clonal population of HeLa cells (Hela-3) were
harvested for western assays via trypsinization (5 min at
37 °C), and then counted with the TC automated cell
counter (Bio-Rad). Cells were then pelleted by centrifu-
gation at 700 rpm for 3 min, then washed with cold
(pre-chilled on ice) PBS 2×. A final pelleting step at
2000 rpm for 3 min occurred before the cell pellets were
resuspended in RIPA buffer (150 mM NaCl, 50 mM
Tris-HCl pH 7.4, 1 mM EDTA, 1 % TritonX-100, 1 %
sodium deoxycholic acid, 0.1 % SDS) at a ratio of 50uL
per one million cells. Cells were lysed through three
cycles of 20 s vortex steps and 5 min on ice, thenn normalized to Actin protein expression in Hela3 cells (a) demonstrates
knockdown). Loss of LARP7 is accompanied by reduction in telomerase
ning (d)
Fig. 2 Telomerase splicing in LARP7 knockdown cells. LARP7
knockdown in Hela3 cells leads to statistically significant reductions
(p < 0.05) in telomerase full-length and -Beta mRNA splicing in both
shRNAs evaluated (n = 3)
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then denatured by incubation at 95 °C for 5 min. Protein
concentration was quantitated with the BCA protein
assay kit (Pierce) according to the manufacturer’s
instructions. Samples were loaded into 10 well pre-
formed Mini Protein TGX gradient polyacrylamide gels
(Bio-Rad) and run at 100 V until the lowest ladder band
reached the bottom of the gel. Proteins were transferred
to a PVDF membrane using a trans-blot turbo pack
(Bio-Rad). The membrane was then washed 2× with
PBST, then blocked with a 5 % milk in PBST solution for
1 h at room temperature on a shaker. The LARP7Fig. 3 Telomere length measurement of LARP7 mutant cohorts. Terminal R
illustrate short lymphocyte telomeres, even in individuals who do not manprimary antibody (Abcam) was used at a concentration
of 1:5000 following blocking and allowed to hybridize
overnight at 4 °C. The membrane was then rinsed 3×
with PBST at room temperature on a shaker. The anti-
rabbit secondary antibody was used at a concentration
of 1:5000 in a 5 % milk PBST solution and incubated at
room temperature for 1 h on a shaker. After administra-
tion of the secondary antibody, the membrane was
washed 3× with PBST, and signal was detected with ECL
plus western blotting detection reagents (Amersham).
Signal was obtained with the G Box imaging system
(Syngene).
Terminal Restriction Fragment (TRF) and droplet digital
Telomere Repeat Amplification Protocol (ddTRAP) assays
were performed as previously described [14, 15]. Analysis
of telomerase splicing was performed as described in [16],
with the exception that PCR and quantitation were per-
formed using the droplet digital PCR platform (Bio-Rad,
Berkeley, CA). Flow-FISH telomere measurement was
accomplished by Repeat Diagnostics, Inc (Vancouver,
Canada) according to their standard methods.
Statistical analysis
Signals from the ddTRAP and splicing assays were
compared via two-tailed t-tests and were considered
significant if P < 0.05. Though Universal STELA was
performed as previously [17, 18], we developed a new
quantification method which streamlines the workflow
and reduces user-induced variability in results. Universal
Single TElomere Length Analysis (STELA), a ligationestriction Fragment (TRF) assays for the Saudi and Canadian cohorts
ifest the developmental symptoms of Alazami syndrome
Fig. 4 Pedigree of LARP7 mutant cohorts. Progressively shorter initial telomere length in successive generations of the LARP7 mutant Saudi cohort
illustrate a pattern of genetic anticipation observed in other telomeropathies. The age (in years) and telomere length (TL) in kilobase pairs (kb) of each
individual in this Saudi Arabian pedigree (left side) are provided in the table (right side). The smaller Canadian cohort is detailed at the bottom of this
figure (providing age and average telomere length)
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short telomeres by small amount of genomic DNA.
However, manual quantification of the length and
dynamics of each telomere band from Universal STELA
is error prone and time consuming. Thus, it is important
to design a program that can effectively and efficiently
identify and analyze those images. We developed a
Matlab-based algorithm which can automatically detect
bands, calculates average telomere size and the ratio of
the short telomeres to the rest based on Universal
STELA gel images. Images are sharpened and back-
ground subtracted to ensure that bands are distinguish-
able. The algorithm then identifies the centers of all
lanes based on the intensity profile, and identifies bands
by locating peaks in the intensity profile. The results are
consistent with the previous manual quantification
method and can be manually adjusted in case there are
false positive/negative outcomes. Furthermore, using this
algorithm makes high throughput analysis possible and
can avoid artificial bias.Results
To determine how LARP7 impacts telomere maintenance,
we stably knocked down LARP7 with three different
shRNA constructs. All three constructs resulted in >90 %
reduction in LARP7 protein abundance (Fig. 1a, b). We
next evaluated the effect of LARP7 knockdown on telomer-
ase enzymatic activity. All three constructs significantly re-
sulted in a decrease in telomerase enzymatic activity (p
< 0.01), with a reduction in telomerase enzymatic
activity between 40 and 80 % (Fig. 1c). This reduction
in telomerase enzymatic activity was accompanied by
progressive telomere shortening in all three cell popula-
tions upon extended passage in tissue culture (Fig. 1d).
These results illustrate that telomerase is not in excess
even in cancer cells such that the remaining telomerase
enzymatic activity in LARP7 stable knockdown cells
was not sufficient to maintain telomere length.
Because LARP7 depletion causes dysregulation of tran-
scriptional elongation as well as aberrant splicing [19], we
next evaluated if LARP7 knockdown resulted in changes
Fig. 5 Flow-FISH analysis of telomere length in the Canadian proband. The individual presenting with Alazami syndrome had lymphocyte telomere
length below the 10th percentile for his age, and telomere length below the 1st percentile for the CD57+ natural killer cell fraction
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LARP7 knockdown caused a significant reduction in full-
length telomerase transcripts as well as a reduction in the
abundance of the –Beta apparently nonfunctional isoform
[20], but did not result in a statistically significant overall
reduction in total telomerase mRNA (Fig. 2). This
suggests that the reduction in telomerase enzymatic
activity was mediated through an effect other than down-
regulation of total telomerase transcription.
In contrast to what would be expected based on the
observations that LARP7 deficiency in Tetrahymena
leads to lower levels of TERC RNA and TERT protein
[9, 12, 13], in human cells we show that LARP7 stable
knockdown does not reduce total telomerase mRNA
levels. However, we did observe a reduction in both
full-length, functional telomerase mRNA, as well as the
non-functional –Beta isoform, indicating a shift toward
a splice form other than the two most abundant forms
of telomerase mRNA.
In order to determine if LARP7 has the same
functions in vivo with regard to telomere maintenance,
we performed telomere length analysis in lymphocyte
DNA extracted from humans with Alazami syndrome,both the cohort originally described [21] as well as in a
Canadian family with a single affected individual (8 years
old) and two parents that were carriers for a distinct
loss-of-function mutation in LARP7 (a one-nucleotide
deletion which causes a frameshift and premature stop,
c.756_757del, p.Arg253Ile*6). The Canadian cohort was
identified through whole-genome sequencing of the pro-
band, who has long standing growth retardation (< -3.5
SD), moderate developmental delays without regression,
axial hypotonia and dysmorphic features (scaphocephalic
with frontal bossing/prominent forehead, depressed and
wide nasal bridge with a mildly bulbous tip of the nose,
telecanthus with mild hypertelorism, prominent ears and
small hands with short distal phalanges and nails). The
proband has normal brain anatomy (via brain MRI/
MRS), small kidneys (R < 5%tile and L between 5 and 10
%tile) (via multiple abdominal ultrasounds), several small
atrial septal defects and mild left pulmonary artery
stenosis, and thin, short distal phalanges of the hands
(via skeletal X-ray survey). He also has longstanding bor-
derline anemia (red blood cell counts in the 3.9–4.3
range, with hematocrits in the 34–38 range), but has not
been symptomatic for anemia. His white blood cell and
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evidence of the hair, nail or skin abnormalities normally
observed in classical Dyskeratosis congenita. Both of his
parents carry one copy of the deletion and have no
history of anemia, lung disease or mucocutaneous
abnormalities.
Telomeres in affected individuals, carriers and wild-
type individuals descended from carriers were all shorter
compared to age matched individuals in the general
population, as well as compared to an unrelated 28-year-
old male control (Fig. 3). Correcting for age-associated
telomere shortening with a rate of telomere shortening
based on previously conducted longitudinal studies
indicates a pattern of anticipation (progressively shorter
initial telomere length with each succeeding generation)
consistent with observations from other telomeropathies
(Fig. 4). Initial telomere length in the Saudi Arabian co-
hort is decreasing inter-generationally, with a difference
of 560 base pairs in initial telomere length between the
generation III and generation IV individuals measured,
or by roughly 30 base-pairs per year.
Flow-FISH analysis of telomere length from the
Canadian proband indicates telomere length in the lowerFig. 6 Universal STELA on the Canadian family. The length of the shortest
with Universal STELA products in the 8-year-old proband roughly compara10th percentile for all leukocytes, with telomere length in
CD57 positive cells below the 1st percentile (Fig. 5).
Universal Single Telomere Length Analysis (Uni-STELA)
can reveal the length of the shortest telomeres, which mat-
ter the most in establishing proliferative limits on the cell
[22]. We utilized Uni-STELA to determine if the Canadian
cohort had a greater abundance of very short telomeres
compared to the control, and to evaluate if there was a dif-
ference between the behavior of the bulk telomere popula-
tion and the shortest telomeres (Fig. 6). Consistent with the
TRF observations, the 8 year old Alazami-syndrome af-
fected proband exhibited Uni-STELA telomere lengths
roughly equivalent to the 28-year old unrelated control,
demonstrating telomere lengths substantially shorter than
expected for the age group. The proband’s father also
displayed a remarkably short Uni-STELA distribution, with
a much greater proportion of Uni-STELA products below
1.6 kb compared to the unrelated control.
Discussion
At least one other La-domain containing protein associ-
ates with telomerase in humans, LARP3 (previously
known as simply La) [8], suggesting that evolutionarilytelomeres was reduced in all three members of the Canadian cohort,
ble to an unrelated 28-year-old male
Fig. 7 Model of the dominant nature of the impaired telomere
maintenance in LARP7 mutant cohorts. In this model, the developmental
defects associated with LARP7 deficiency are recessive, whereas the
impaired telomere maintenance and inheritance of short telomeres can
be transmitted even from heterozygous, overtly normal individuals. Thus
the telomere length phenotype of LARP7 deficiency/Alazami syndrome
displays a dominant inheritance modality with genetic anticipation in
telomere shortening
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allocated to separate La-domain family proteins in
humans. This is one possible explanation for the differ-
ences between the results of depletion of human LARP7
and Tetrahymena p65. It is also possible that the reduc-
tion in telomerase enzymatic activity observed is due to
the loss of some aspect of the telomerase holoenzyme
assembly, processivity or to the loss of full-length TERT
mRNA in the LARP7 knockdown cells. The relative
reduction in full-length transcript abundance is compar-
able to the reduction in telomerase enzymatic activity.
The observation that even wild-type individuals in the
Saudi Arabian LARP7 cohort have very short telomeres
is consistent with what is observed in other telomeropa-
thies, because all wild-type individuals in that cohort are
descended from at least two generations of LARP7
mutation carriers. Telomere lengths in those individuals
are comparable to wild-type offspring of carriers of
nonfunctional TERT alleles [23], suggesting a similarly
severe defect in telomere maintenance occurs in the
context of LARP7 deficiency. A number of individuals in
these families are pre-pubescent, in age ranges wherein
telomere shortening is faster than it is in adulthood, and
the age-associated shortening rate used to correct for
age does not account for this. Thus, it is likely that initial
telomere lengths in the most recent generation of the
Saudi cohort have not actually stabilized because of this
inadequacy in the age correction.
The Canadian family displays a similar pattern of
shorter than average telomere length and progressively
shorter initial telomere length, albeit to a lesser degree
than the Saudi family. Though a number of individuals
in the Saudi cohort exhibited microcytic anemia and the
Canadian proband exhibited borderline anemia, these
could be due to environmental factors such as malnutri-
tion or be otherwise unrelated to the telomere phenotype.
Anemia and specific lymphocytopenias are consistent with
the symptoms of a telomeropathy [23–25], but the pheno-
types observed in these cohorts are not severe enough to
say with certainty that they arise from impaired telomere
maintenance.
Because two different cohorts with two distinct loss-
of-function mutations in LARP7 display a similar pattern
of symptoms as well as impaired telomere maintenance,
it is likely that the short telomere phenotype observed
here is due to the pathology rather than an inter-ethnic
or inter-regional difference in mean telomere length,
which has been reported [26]. Because both wild-type
and individuals heterozygous for a loss-of-function
mutation in LARP7 display short telomeres and progres-
sively shorter initial telomere length, it is reasonable to
assume the developmental symptoms of Alazami
syndrome are distinct from the telomeric symptoms. We
propose a model (Fig. 7) in which an equilibriumtelomere length in germ cell progenitors is disrupted
even in the context of reduced function of LARP7,
haploinsufficiency in the telomeric aspects of LARP7
function, while LARP7’s other functions are sufficiently
robust that the developmental phenotypes of Alazami
syndrome are recessive in nature.
Conclusions
We investigated if humans with LARP7 deficiency exhib-
ited symptoms of a telomeropathy or displayed enhanced
telomere shortening with time in a previously described
cohort of individuals with LARP7 deficiency (Alazami
syndrome) [21] as well as another family identified with a
mutation in LARP7. We first determined the effects of
LARP7 knockdown on telomere length, telomerase
(hTERT) splicing and enzymatic activity in human cell
culture models, and then assessed the telomere biology of
both affected and unaffected relatives of Alazami syn-
drome patients. We discovered that LARP7 knockdown
induces progressive time-dependent telomere shortening
concomitant with a reduction in telomerase enzymatic
activity and a decrease in full-length (catalytically active)
TERT mRNA in vitro, and that humans with LARP7
deficiency display dramatically short telomeres, borderline
anemia in younger generations, and anticipation consist-
ent with a telomeropathy.
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